IQQL:XETRA:XETRA-iShares Listed Private Equity UCITS (EUR)

ETF | Others |

Last Closing

USD 32.18

Change

-0.24 (-0.74)%

Market Cap

USD 0.79B

Volume

9.36K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.14 (-0.28%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.34%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.07 (-0.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.09 (-0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.04 (-0.14%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.64 (+0.45%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.13%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.42%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.21 (-0.21%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.18 (-0.03%)

USD 80.38B

ETFs Containing IQQL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.76% 77% C+ 76% C+
Dividend Return 1.90% 62% D 45% F
Total Return 18.66% 84% B 82% B
Trailing 12 Months  
Capital Gain 33.94% 90% A- 88% B+
Dividend Return 4.41% 92% A 77% C+
Total Return 38.35% 92% A 89% A-
Trailing 5 Years  
Capital Gain 62.89% 76% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.89% 76% C+ 74% C
Average Annual (5 Year Horizon)  
Capital Gain 14.12% N/A N/A 81% B-
Dividend Return 15.87% N/A N/A 84% B
Total Return 1.76% N/A N/A 65% D
Risk Return Profile  
Volatility (Standard Deviation) 25.83% N/A N/A 22% F
Risk Adjusted Return 61.46% N/A N/A 66% D+
Market Capitalization 0.79B 73% C 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike